Logo Image
|Articles|March 27, 2018

Launch of Cannabis Science and Technology Magazine

Our new sister publication, Cannabis Science and Technology (CST), launched in March 2018. In alliance with the Cannabis Science Conference, this new professional journal and website will focus on educating the legal cannabis industry about the science and technology of analytical testing and quality control, including topics such as   

· Sample preparation techniques for analytical testing

· Development of analytical methods for potency testing

· Identifying contaminants such as pesticides, residual solvents, heavy metals, and mycotoxins

· Quality control for cannabis, extraction, and processing

· Laboratory best practices and certification

· Testing standardization

· Regulations related to quality control

The first issue features content ranging from quality assurance, laboratory accreditation, analytical tools to analyze edibles, metals analysis, extraction processes, and more. To read the full issue, please visit www.cannabissciencetech.com/journal/cannabis-science-and-technology-vol-1-no-1 or download the digital edition.

If you would like to submit an article to Cannabis Science and Technology, contact Meg L’Heureux, Editor-in-Chief at [email protected].  

For subscription information, please visit http://www.cannabissciencetech.com/subscribe

Related to this article

View more
© C Davids/peopleimages.com - © C Davids/peopleimages.com - stock.adobe.com
What "Patient Voice" Actually Requires: Beyond the Buzzword
The clinical research industry talks about patient-centeredness constantly but embeds it too late, too narrowly, and without clear ownership, and the cost shows up in enrollment failures, protocol deviations, and outcomes that don't reflect what patients actually care about.
Read more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more